Product Highlight - Tabrecta

17 Jun 2022
Product Highlight - Tabrecta
Active ingredient: Capmatinib.

Indication: Adults w/ metastatic non-small cell lung cancer (NSCLC) w/ a MET exon 14 skipping mutation.

Dosage & Administration: Recommended dose: 400 mg PO bid w/ or w/o food.

NOVARTIS (THAILAND) LTD
689 Bhiraj Tower at EmQuartier, 25th Fl.,
Sukhumvit Rd, North Klongton Sub-District,
Vadhana District, Bangkok 10110
Tel: (+66) 2080 0999 • Fax: (+66) 2028 9799

Related MIMS Drugs